Dr. John Galvin is an Assistant Professor in the Department of Clinical Medicine. His overall research is focused on Blood and Marrow Transplantation (BMT). Dr. Galvin’s current research focuses on investigating the biology of Graft versus Host Disease (GvHD) and potential targets for clinical therapies. His graduate work focused on unraveling the biology of T-cell maturation, apoptosis and immune response to apoptotic cells. The immunologic effect of apoptotic cells and nanoparticles on T-cell activation has been the current focus of his basic immunology research. Dr. Galvin has also recently worked on clinical research that focuses on both novel cellular therapies and supportive care for patients before, during and after stem cell transplant.
His research is focused on Blood and Marrow Transplantation (BMT).